After Esophagectomy Application Aidi Injection Is The Plasma Scd44s Clinical Studies

Objective A great deal research show, for the moment, transfer and recur after operation are still main reasons for tumor sufferer's death, Occurrence and development of tumor is tied-up closely with system immunoreaction. Red blood cell immunity (RCI) is one important part of immunity, improving RCI function can restrain tumor to transfer.The objective of this research is to study the influence of aidi injection on RCI and tumor transfer in molecule level, by measuring plasma sCD44s, investigating its function on esophageal carcinoma patients after operation early, deepen the research, offer theory proof for apply resist tumor Chinese traditional medicine during all-around operation, to establish clinic study base for explore new generation of resist tumor Chinese traditional medicine.Method We totally got 9 patients, apply early aidi injection after operation on experimental group, control group not yet. Measure plasma sCD44s through ELISA, eualuate aidi injection function on immunity.Result The pre-treatment blood plasma sCD44s level the controlgroup blood plasma sCD44s level is x ± s =249.80 ± 66.71ng/ml, theexperimentation group blood plasma sCD44s level is x ± s =239.25 ± 72.20ng/ml, by t test , P=0.41>0.05, there is no significant difference in statistics between the two groups. After treatment blood plasma sCD44s level the experimentation groupblood plasma sCD44s level is x ± s =159.67 ± 74.57ng/ml, the controlgroup blood plasma sCD44s level is x ± s =353.33 ± 60.93ng/ml, by t test, P=0.01<0.05, there is significant difference in statistics between the two groups.Conclusion The pre-treatment blood plasma sCD44s level of two...